BACKGROUND: The biological patch is an importance substitute of the pelvic floor tissue, it that can replace damaged weak pelvic fascia, has been more and more widely used in pelvic floor reconstruction. However, the efficacy and biocompatibility are rarely reported.
OBJECTIVE: To introduce clinical application progress of biological patch in female pelvic floor reconstruction, and to evaluate the biocompatibility of various patch materials with the host.
METHODS: A computer search was performed by the first author in China Academic Journal Full-text Database (CNKI: 1990/2010) and Medline database (1990/2010), using the key words of “patch, obstetrics and gynecology diseases, treatment” in Chinese and “obstetrics, gynecology diseases, treatment” in English. Eventually 26 in accordance with the inclusive criteria were included and summarized at the following two aspects: clinical application progress of the patch in female pelvic floor reconstruction, and both biocompatibility and complications after patch implantation.
RESULTS AND CONCLUSION: The patch implantation mainly shows good effects in treatment of female pelvic floor dysfunction diseases, including full pelvic reconstruction, vaginal anterior and posterior wall repair, and vaginal vault suspension. In all types of implants, autologous tissue, allografts, xenografts are vulnerable to infection and wear after implantation, with poor biocompatibility, so they are not suitable as the reconstruction materials. The synthetic absorbable patch is strong and convenient, but prone to infection, rejection, erosion and other complications, with poor biocompatibility. The non-absorbing synthetic patch and acellular patch show a lower infection rate, fewer complications, and better biocompatibility. In patch implantation, biological patch should be free from tension state, and be manipulated at aseptic conditions, avoiding any permanent sutures through the vaginal mucosa and closely stop bleeding, thus reducing the incidence of complications.